Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nneka Nwokolo

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical Pharmacokinetics|March 4, 2015
Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesNneka Nwokolo, Marta Boffito
Sexually Transmitted Infections|March 10, 2018
Syphilis the great pretender: when is cancer not cancer?Neesha Rockwood, Nneka Nwokolo
BMJ (Clinical Research Ed.)|June 30, 2012
Dizziness and rash in an HIV positive manDaniel Bradshaw, Nneka Nwokolo
International Journal of STD & AIDS|July 24, 2020
Does qualitative viral load testing shorten the window period for diagnosing HIV in individuals attending for post-exposure prophylaxis?Gary Whitlock, Nneka Nwokolo,
Journal of HIV Therapy|September 3, 2003
Effect of treatment for sexually transmitted disease on HIV transmissionRita Browne, Nneka Nwokolo, Fiona Boag
The Lancet. HIV|April 1, 2017
Not just PrEP: other reasons for London's HIV declineNneka Nwokolo, Gary Whitlock, Alan McOwan
BMJ (Clinical Research Ed.)|September 28, 2011
A patient with rectal discharge and feverKate Atkinson, Daniel M Bradshaw, Nneka Nwokolo
Clinical Pharmacokinetics|October 22, 2014
Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesVictoria Tittle, Lauren Bull, Marta Boffito, et al.
Post Reproductive Health|December 19, 2017
HIV and the menopause: A reviewLauren Bull, Victoria Tittle, Taslima Rashid, et al.
The Lancet. HIV|October 26, 2017
Rapidly declining HIV infection in MSM in central LondonNneka Nwokolo, Andrew Hill, Alan McOwan, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|March 4, 2015
Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesNneka Nwokolo, Marta Boffito
Sexually Transmitted Infections|March 10, 2018
Syphilis the great pretender: when is cancer not cancer?Neesha Rockwood, Nneka Nwokolo
BMJ (Clinical Research Ed.)|June 30, 2012
Dizziness and rash in an HIV positive manDaniel Bradshaw, Nneka Nwokolo
International Journal of STD & AIDS|July 24, 2020
Does qualitative viral load testing shorten the window period for diagnosing HIV in individuals attending for post-exposure prophylaxis?Gary Whitlock, Nneka Nwokolo,
Journal of HIV Therapy|September 3, 2003
Effect of treatment for sexually transmitted disease on HIV transmissionRita Browne, Nneka Nwokolo, Fiona Boag
The Lancet. HIV|April 1, 2017
Not just PrEP: other reasons for London's HIV declineNneka Nwokolo, Gary Whitlock, Alan McOwan
BMJ (Clinical Research Ed.)|September 28, 2011
A patient with rectal discharge and feverKate Atkinson, Daniel M Bradshaw, Nneka Nwokolo
Clinical Pharmacokinetics|October 22, 2014
Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesVictoria Tittle, Lauren Bull, Marta Boffito, et al.
Post Reproductive Health|December 19, 2017
HIV and the menopause: A reviewLauren Bull, Victoria Tittle, Taslima Rashid, et al.
The Lancet. HIV|October 26, 2017
Rapidly declining HIV infection in MSM in central LondonNneka Nwokolo, Andrew Hill, Alan McOwan, et al.
Pageof 6